Grifols

HYPERTET S-D

Manufacturer:

Grifols

Hypertet S-D HCPCS:

J1670

HCPCS Code Descriptor:

Injection, tetanus immune globulin, human, up to 250 units

Category:

J Code

Hypertet S-D NDCs:

13533-0634-02

Primary Type:

Immunoglobulin

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Hypertet S-D:

HYPERTET S-D is an Immunoglobulin drug manufactured by Grifols and administered via the Intramuscular route of administration. The J Code: J1670 is aligned to the drug HYPERTET S-D.

ACCESS PRICING AND MORE BY REGISTERING

J1670 Added Date:

January 1, 1986

J1670 Effective Date:

January 1, 1997

J1670 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Hypertet S-D billing and coding information.
Our team did not identify a source for Hypertet S-D patient assistance information. Please reach out to our team if you feel that this is a mistake.
HYPERTET S-D prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for HYPERTET S-D. Please check back in a few weeks.